A robust response to high-dose plasma, prednisolone, and rituximab in an infant with acquired thrombotic thrombocytopenic purpura

Pediatr Blood Cancer. 2023 May 12:e30416. doi: 10.1002/pbc.30416. Online ahead of print.

Authors

Mari Suzuki¹, Katsuyoshi Shimozawa¹, Hiroshi Yagasaki¹, Masaru Ueno¹, Maiko Hirai¹, Masanori Matsumoto², Ichiro Morioka¹

Affiliations

¹ Department of Pediatrics and Child health, Nihon University School of Medicine, Tokyo, Japan.
² Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan.

PMID: 37170850
DOI: 10.1002/pbc.30416

No abstract available

Publication types

Letter